Lysosomal hydrolases in cerebrospinal fluid from subjects with Parkinson's disease-Reference-Cited by-同舟云学术

Lysosomal hydrolases in cerebrospinal fluid from subjects with Parkinson's disease

Published:2007-06 Issue:10 Volume:22 Page:1481-1484
ISSN:0885-3185
Container-title:Movement Disorders
language:en
Short-container-title:Mov. Disord.

Author:

Balducci Chiara¹,Pierguidi Laura²³,Persichetti Emanuele¹,Parnetti Lucilla²,Sbaragli Michele¹,Tassi Carmelo⁴,Orlacchio Aldo⁴,Calabresi Paolo²³,Beccari Tommaso¹,Rossi Aroldo²

Affiliation:

1. Dipartimento di Medicina Interna, Università degli Studi di Perugia, Perugia, Italy

2. Clinica Neurologica, Ospedale Santa Maria della Misericordia, Università degli Studi di Perugia, Perugia, Italy

3. Fondazione Santa Lucia, IRCCS, Roma, Italy

4. Dipartimento di Medicina Sperimentale e Scienze Biochimiche, Università degli Studi di Perugia, Perugia, Italy

Publisher

Wiley

Subject

Neurology (clinical),Neurology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/mds.21399

Reference15 articles.

1. Parkinson's Disease

2. Glucocerebrosidase mutations in subjects with parkinsonism

3. Gaucher's disease with Parkinson's disease: Clinical and pathological aspects

4. PREDICTION OF SEVERITY OF GAUCHER'S DISEASE BY IDENTIFICATION OF MUTATIONS AT DNA LEVEL

5. Methylenetetrahydrofolate reductase genotypes and predisposition to atherothrombotic disease. Evidence that all three MTHFR C677T genotypes confer different levels of risk

Cited by 102 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Lysosomal dysfunction in α-synuclein pathology: molecular mechanisms and therapeutic strategies;Cellular and Molecular Life Sciences;2024-09-03

2. Expanding the Neurological Phenotype of Anderson–Fabry Disease: Proof of Concept for an Extrapyramidal Neurodegenerative Pattern and Comparison with Monogenic Vascular Parkinsonism;Cells;2024-06-29

3. Advancements in Genetic and Biochemical Insights: Unraveling the Etiopathogenesis of Neurodegeneration in Parkinson’s Disease;Biomolecules;2024-01-05

4. Clinical biomarkers for Lewy body diseases;Cell & Bioscience;2023-11-14

5. GBA1 Variants and Parkinson’s Disease: Paving the Way for Targeted Therapy;Journal of Movement Disorders;2023-09-30